A new FDA advisory panel meeting, influenced by RFK Jr.'s push for broader access, will weigh the potential benefits and risks of widely promoted peptides. Click the link in bio to read Covering Every FDA Oncology Approval From October 2025 CURE In 2023, the FDA deemed 19 peptides too unsafe to be dispensed by compounding pharmacies. Now, under RFK Jr., the agency is poised to reverse itself despite the fact that few Is BPC 157 Banned? Oral vs. Injectable Forms Explained FDA Decisions Expected: October 2025 Prime Therapeutics Portal